Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome
Status:
Not yet recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Polycystic ovary syndrome is the most common endocrine and metabolic disorder in gynecology.
Traditional Chinese medicine has a good clinical effect in the treatment of PCOS. We intend
to conduct this trial in strict accordance with the requirements of evidence-based medicine,
through a multi-center, randomized, controlled study, using a double-blind, randomized,
placebo-controlled study design method to clarify that Zishen Qingre Lishi Huayu Recipe
restores spontaneous ovulation in PCOS patients. The overall efficacy of improving the
characteristics of Kaohsiung and glucose and lipid metabolism is optimal, and high-level
evidence-based evidence is obtained to form a diagnosis and treatment plan for promotion.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Jiangxi University of Traditional Chinese Medicine